GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Double Bond Pharmaceutical International AB (XSAT:DBP B) » Definitions » 3-Year Sharpe Ratio

Double Bond Pharmaceutical International AB (XSAT:DBP B) 3-Year Sharpe Ratio : 0.28 (As of Jun. 26, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Double Bond Pharmaceutical International AB 3-Year Sharpe Ratio?

The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2025-06-26), Double Bond Pharmaceutical International AB's 3-Year Sharpe Ratio is 0.28.


Competitive Comparison of Double Bond Pharmaceutical International AB's 3-Year Sharpe Ratio

For the Biotechnology subindustry, Double Bond Pharmaceutical International AB's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Double Bond Pharmaceutical International AB's 3-Year Sharpe Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Double Bond Pharmaceutical International AB's 3-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Double Bond Pharmaceutical International AB's 3-Year Sharpe Ratio falls into.


;
;

Double Bond Pharmaceutical International AB 3-Year Sharpe Ratio Calculation

The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.


Double Bond Pharmaceutical International AB  (XSAT:DBP B) 3-Year Sharpe Ratio Explanation

The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Double Bond Pharmaceutical International AB 3-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Double Bond Pharmaceutical International AB's 3-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Double Bond Pharmaceutical International AB Business Description

Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.

Double Bond Pharmaceutical International AB Headlines

No Headlines